Late‐onset AGEP ‐like skin pustular eruption following COVID ‐19: A possible association
Authors:
- 4 September 2020
- journal article
- letter
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (6) , e14275
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cutaneous manifestations of SARS‐CoV‐2 infection: a clinical updateJournal of the European Academy of Dermatology and Venereology, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- NKp46+ cells express granulysin in multiple cutaneous adverse drug reactionsAllergy, 2011
- Increased circulating Th17 frequencies and serum IL‐22 levels in patients with acute generalized exanthematous pustulosisJournal of the European Academy of Dermatology and Venereology, 2011
- Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor‐α antibody infliximab: report of three casesJournal of the European Academy of Dermatology and Venereology, 2007
- T-cell involvement in drug-induced acute generalized exanthematous pustulosisJournal of Clinical Investigation, 2001
- Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction patternJournal of Cutaneous Pathology, 2001
- Acute Generalized Exanthematous PustulosisArchives of Dermatology, 1991